Search Results
Search for other papers by Gabriela Hernández-Puga in
Google Scholar
PubMed
Search for other papers by Arturo Mendoza in
Google Scholar
PubMed
Search for other papers by Alfonso León-del-Río in
Google Scholar
PubMed
Search for other papers by Aurea Orozco in
Google Scholar
PubMed
recruitment of specific sets of coregulators. To follow-up on this hypothesis, in the present study, we aimed to identify possible ligand-specific recruitment of coregulators to TRB1 isoforms. Here, we identified Jab1 as a TRB1 partner and showed that this
Search for other papers by ME Pyle in
Google Scholar
PubMed
Search for other papers by M Korbonits in
Google Scholar
PubMed
Search for other papers by M Gueorguiev in
Google Scholar
PubMed
Search for other papers by S Jordan in
Google Scholar
PubMed
Search for other papers by B Kola in
Google Scholar
PubMed
Search for other papers by DG Morris in
Google Scholar
PubMed
Search for other papers by A Meinhardt in
Google Scholar
PubMed
Search for other papers by MP Powell in
Google Scholar
PubMed
Search for other papers by FX Claret in
Google Scholar
PubMed
Search for other papers by Q Zhang in
Google Scholar
PubMed
Search for other papers by C Metz in
Google Scholar
PubMed
Search for other papers by R Bucala in
Google Scholar
PubMed
Search for other papers by AB Grossman in
Google Scholar
PubMed
Macrophage migration inhibitory factor (MIF) is an essential regulator of the macrophage responses to endotoxin. MIF also has the ability to override the anti-inflammatory actions of glucocorticoids during an immune response, and is thus an important pro-inflammatory factor. The presence of MIF in cells of the anterior pituitary has been described, and high levels of MIF in other rapidly proliferating tIssues have also been demonstrated. It has been hypothesised that MIF release from these cells is influenced by the hypothalamo-pituitary-adrenal axis, and that ACTH and MIF are released simultaneously to exert counter-regulatory effects on cortisol. However, another intracellular role for MIF has also been suggested as it has been shown that MIF exerts an effect on the inhibitory cell cycle control protein p27 through an interaction with Jab1, a protein implicated in p27 degradation. We studied MIF expression in different normal and adenomatous human pituitary samples using immunohistochemistry and RT-PCR. There was evidence of co-immunoprecipitation of MIF with Jab1, suggesting an interaction of the two proteins. Our results showed that there is increased expression of MIF protein in the nuclei of all pituitary adenomas compared with normal tIssue (P=0.0067), but there was no statistically significant difference in nuclear MIF expression between the different adenoma types. Nuclear MIF expression correlated positively with p27 and its phosphorylated form in normal tIssue (P=0.0028 and P<0.0001); however, this relationship was not seen in the adenoma samples. Cytoplasmic expression of MIF was found to be variable both in normal and adenomatous samples, with no consistent pattern. MIF mRNA was demonstrated to be present in all tumour and normal samples studied. Somatotroph tumours showed higher MIF mRNA expression compared with normal pituitary or other types of adenomas. In conclusion, MIF is expressed in cell nuclei in pituitary adenomas to a greater extent than in normal pituitary tIssue. We speculate that it may play a role in the control of the cell cycle, but whether its higher level in adenomas is a cause or a consequence of the tumorigenic process remains to be clarified.
Search for other papers by RP Donn in
Google Scholar
PubMed
Search for other papers by DW Ray in
Google Scholar
PubMed
The immunological and neuroendocrine properties of macrophage migration inhibitory factor (MIF) are diverse. In this article we review the known cellular, molecular and genetic properties of MIF that place it as a key regulatory cytokine, acting within both the innate and adaptive immune responses.The unexpected and paradoxical induction of MIF secretion by low concentrations of glucocorticoids is explored. The role of MIF as a locally acting modulator of glucocorticoid sensitivity within foci of inflammation is also discussed. MIF has no homology with any other pro-inflammatory cytokine and until recently lacked a recognised transmembrane receptor. MIF has also been shown to be directly taken up into target cells and to interact with intracellular signalling molecules, including the Jun activation domain-binding protein Jab-1.Comprehensive analysis of the MIF gene has identified important functional polymorphisms and a series of genetic studies has revealed both association and linkage of MIF with inflammatory diseases. Altered MIF regulation may therefore be pivotal to acquiring chronic inflammation following an innate immune response.
Search for other papers by Hyo Youl Moon in
Google Scholar
PubMed
Search for other papers by Parkyong Song in
Google Scholar
PubMed
Search for other papers by Cheol Soo Choi in
Google Scholar
PubMed
Search for other papers by Sung Ho Ryu in
Google Scholar
PubMed
Search for other papers by Pann-Ghill Suh in
Google Scholar
PubMed
activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity . Cell Signalling 18 688 – 703 . ( doi:10.1016/j.cellsig.2005.06.013 ) McGarry JD Brown NF 1997 The
Search for other papers by Márta Szaszák in
Google Scholar
PubMed
Search for other papers by Hung-Dar Chen in
Google Scholar
PubMed
Search for other papers by Hao-Chia Chen in
Google Scholar
PubMed
Search for other papers by Albert Baukal in
Google Scholar
PubMed
Search for other papers by László Hunyady in
Google Scholar
PubMed
Search for other papers by Kevin J Catt in
Google Scholar
PubMed
Kapurniotu A Fingerle-Rowson G Roger T Leng L Thiele M Calandra T Bucala R Bernhagen J 2006 Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and
